GILD : Insider Transactions for Gilead Sciences Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Gilead Sciences Inc (GILD)

$83.04

0.83 (1.01%) as of 4:30 Thu 9/26

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

1,250,000,000

Market Cap:

103.80(B)

Last Volume:

5,653,468

Avg Vol:

8,557,973

52 Week Range:

$63.15 - $87.29

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	S&P COMPOSITE 1500		NASDAQ BIOTECHNOLOGY
	NASDAQ COMPOSITE		NASDAQ-100
	S&P 500		NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 425

Guru Rank Value : 4.8

Guru Occurances : 3


6 Months 1 Year 2 Year

Company Profile Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	67,606	69,606	98,078	148,398
Total Sell Value	$5,540,573	$5,686,493	$7,962,860	$11,985,869
Total People Sold	2	2	3	4
Total Sell Transactions	5	6	11	19
End Date	2024-06-27	2024-03-26	2023-09-26	2022-09-26

Adjust Filter Settings

Records found: 2533

Page 27 of 102

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Washington Robin L

EVP, CFO

• • –

2017-02-28

4

GA

$0.00

$0

I/I

11,804

121,547

-

Washington Robin L

EVP, CFO

• • –

2017-02-28

4

GD

$0.00

$0

D/D

11,804

9,602

-

Director

• • –

2017-02-23

4

S

$69.30

$1,411,374

D/D

(20,365)

120,471

-

Director

• • –

2017-02-23

4

OE

$20.71

$690,512

D/D

33,350

140,836

-

Milligan John F

President and CEO

• • –

2017-02-23

4

OE

$21.58

$2,157,500

D/D

100,000

1,165,924

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-02-21

4

GD

$0.00

$0

D/D

1,430

122,988

-

Washington Robin L

EVP, CFO

• • –

2017-02-16

4

D

$70.31

$549,402

D/D

(7,814)

21,406

-

Washington Robin L

EVP, CFO

• • –

2017-02-16

4

A

$0.00

$0

D/D

7,701

29,220

-

EVP Worldwide Commercial Ops

• • –

2017-02-16

4

GA

$0.00

$0

I/I

4,354

125,505

-

EVP Worldwide Commercial Ops

• • –

2017-02-16

4

GD

$0.00

$0

D/D

4,354

2,715

-

EVP Worldwide Commercial Ops

• • –

2017-02-16

4

D

$70.31

$144,346

D/D

(2,053)

7,069

-

EVP Worldwide Commercial Ops

• • –

2017-02-16

4

A

$0.00

$0

D/D

2,183

9,122

-

Milligan John F

President and CEO

• • –

2017-02-16

4

D

$70.31

$589,831

D/D

(8,389)

1,065,924

-

Milligan John F

President and CEO

• • –

2017-02-16

4

A

$0.00

$0

D/D

15,035

1,074,313

-

Executive Chairman

• • –

2017-02-16

4

D

$70.31

$1,776,804

D/D

(25,271)

3,126,636

-

Executive Chairman

• • –

2017-02-16

4

A

$0.00

$0

D/D

20,496

3,151,907

-

Bischofberger Norbert W

EVP, R&D and CSO

• • –

2017-02-16

4

GA

$0.00

$0

I/I

11,558

2,318,407

-

Bischofberger Norbert W

EVP, R&D and CSO

• • –

2017-02-16

4

GD

$0.00

$0

D/D

11,558

12,453

-

Bischofberger Norbert W

EVP, R&D and CSO

• • –

2017-02-16

4

D

$70.31

$497,092

D/D

(7,070)

24,011

-

Bischofberger Norbert W

EVP, R&D and CSO

• • –

2017-02-16

4

A

$0.00

$0

D/D

8,794

31,081

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-02-16

4

D

$70.31

$462,429

D/D

(6,577)

124,418

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-02-16

4

A

$0.00

$0

D/D

7,716

130,995

-

Washington Robin L

EVP, CFO

• • –

2017-02-15

4

A

$59.33

$18,689

D/D

315

21,519

-

EVP Worldwide Commercial Ops

• • –

2017-02-15

4

A

$59.33

$12,637

D/D

213

6,939

-

Milligan John F

President and CEO

• • –

2017-02-15

4

A

$59.33

$18,689

D/D

315

1,059,278

-

2533 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 27 of 102

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.